Coordination Behavior of N, N′, N″-Trisubstituted Guanidine Ligands in Their Ru-Arene Complexes: Synthetic, DNA/Protein Binding, and Cytotoxic Studies

Keyphrases

• Trisubstituted 100%
• DNA-binding Proteins 100%
• Coordination Behavior 100%
• Synthetic DNA 100%
• Ru(II)-arene 100%
• P-cymene 100%
• Cytotoxic Studies 100%
• Protein Binding Study 100%
• Guanidine Ligands 100%
• Ru(II) Complexes 66%
• UV-VIS Spectroscopy 66%
• Benzene 66%
• Monometallic 66%
• Cisplatin 66%
• Viscosity 33%
• IC50 Value 33%
• Bovine Serum Albumin 33%
• Apoptosis 33%
• Ruthenium Complexes 33%
• Single Crystal X-ray Crystallography 33%
• Irm-NMR 33%
• Spectroscopic Techniques 33%
• A549 Cells 33%
• Fourier Transform Infrared Spectroscopy (FT-IR) 33%
• Bimetallic 33%
• Hydrophobicity 33%
• HepG2 Cells 33%
• Anticancer Drugs 33%
• MTT Assay 33%
• Bidentate 33%
• In Vitro Cytotoxicity 33%
• Metastatic Tumor 33%
• Cell Death Pathways 33%
• Interaction with Calf-thymus DNA 33%
• DNA Binding Affinity 33%
• Phase II Clinical Trial 33%
• Vero Cells 33%
• Flow Cytometry Method 33%
• KP1019 33%
• HepG2 Cell Line 33%
• NAMI-A 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Cisplatin 100%
• Synthetic DNA 100%
• DNA Binding Protein 100%
• Guanidine 100%
• Polycyclic Aromatic Hydrocarbon 100%
• IC50 50%
• Metastasis 50%
• Flow Cytometry 50%
• Bovine Serum Albumin 50%
• Clinical Trial 50%
• Anticarcinogen 50%
• Hydrophobicity 50%
• Ruthenium Complex 50%
• Cytotoxicity 50%

Chemistry

• Deoxyribonucleic Acid 100%
• Guanidine 100%
• UV/VIS Spectroscopy 66%
• Cisplatin 66%
• Benzene 66%
• Kd 33%
• Ruthenium 33%
• NMR Spectroscopy 33%
• Single Crystal X-Ray Diffraction 33%
• Spectroscopy 33%
• IC50 33%
• Hydrophobicity 33%
• Antineoplastic Agent 33%
• Cytometry 33%
• MTT Assay 33%
• KP1019 33%
• stability 33%
• Fourier Transform Infrared Spectroscopy 33%
• Cell Death 33%